Results 151 to 160 of about 5,761 (217)

Use of microbiome analysis as a complementary endpoint in clinical trials. [PDF]

iScience
Velo-Suarez L, Guilloux CA, Le Berre R, Gouriou S, Rault G, Mottier D, Meijer L, Héry-Arnaud G.   +7 more
europepmc   +1 more source

From CFTR to a CF signalling network: a systems biology approach to study Cystic Fibrosis. [PDF]

BMC Genomics
Najm M, Martignetti L, Cornet M, Kelly-Aubert M, Sermet I, Calzone L, Stoven V.   +6 more
europepmc   +1 more source

Exploring the role of readthrough-inducing molecule 2,6-diaminopurine to increase immune response against cancer cells. [PDF]

Mol Ther
Sandoval Pacheco C, Leroy AM, Derhourhi M, Cardon T, Leroy C, Jouy N, Com E, Guevel B, Bourette R, Carrard J, Barros D, Duchêne B, Toussaint B, Froguel P, Jonckheere N, Chassat T, Van Seuningen I, Lavigne R, Pineau C, Pierre P, Soncin F, Salzet M, Bonnefond A, Lejeune F.   +23 more
europepmc   +1 more source

CFTR mutation is associated with bone differentiation abnormalities in cystic fibrosis. [PDF]

J Cyst Fibros
Dumortier C, Frauenpreis A, Hoarau A, Ryan AL, Gangloff SC, Danopoulos S, Velard F, Al Alam D.   +7 more
europepmc   +1 more source

Rinosinusites na prática clínica: guia de diagnóstico e tratamento [PDF]

, 2010
Barros, E, Branco, C, Branco, G, Caroça, C, Paço, J, Ruah, C, Ruah, S, Vilhena de Mendonça, F   +7 more
core  

Intracellular Pseudomonas aeruginosa persist and evade antibiotic treatment in a wound infection model. [PDF]

PLoS Pathog
Pont S, Nilly F, Berry L, Bonhoure A, Alford MA, Louis M, Nogaret P, Bains M, Lesouhaitier O, Hancock REW, Plésiat P, Blanc-Potard AB.   +11 more
europepmc   +1 more source

Pre-adsorption of serum albumin on biomaterial surfaces modulates bacteria-surface interactions and alters bacterial physiological responses. [PDF]

Mater Today Bio
Le H, Droniou M, Wallart L, Coquet L, Thebault P, Guillou C, Cosette P.   +6 more
europepmc   +1 more source

<i>Cis</i>-Regulation of the <i>CFTR</i> Gene in Pancreatic Cells. [PDF]

Int J Mol Sci
Blotas C, Le Nabec A, Collobert M, Bulcaen M, Carlon MS, Férec C, Moisan S.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Aérosolthérapie dans la mucoviscidose.

Revue des Maladies Respiratoires, 2008
Introduction La prescription de traitements par voie respiratoire est particulierement seduisante dans la mucoviscidose, malgre un depot pulmonaire tres heterogene et variable. Etat des connaissances Les traitements proposes sont essentiellement ceux ayant pour but d’ameliorer la qualite du mucus (serum sale hypertonique ou RhDNase en nebulisation,
J-C Dubus, S. Ravilly
openaire   +1 more source

Aspergillose et mucoviscidose

Archives de Pédiatrie, 2003
Allergic bronchopulmonary aspergillosis (ABPA) should be suspected in any CF patient whose pulmonary disease deteriorates precipitously, suddenly or unexpectedly, and has to be correlated to fungal hypersensitivity biological tests. The standard therapeutic approach is based upon systemic corticosteroids.
M Guillot, C El Hachem, M Amiour, B Delaisi, P Reinert   +4 more
openaire   +1 more source